Schizophrenia Drugs Are Finally Getting an Overhaul | WIRED

Current antipsychotics are plagued by patchy efficacy and unwanted side effects—but a new treatment could change all that.

Save this story Save this story On December 11, 1951, in the labs of French pharmaceutical company Rhône-Poulenc, chemist Paul Charpentier concocted a drug that would change the field of psychiatry forever. Charpentier hadn’t intended to spark a revolution; he was actually trying to make a better antihistamine. But by tweaking an existing drug called promazine, he ended up making a new compound called chlorpromazine. The drug was passed on to a surgeon by the name of Henri Laborit, who was on the hunt for a more effective anesthetic. He noticed it produced a calming effect in his patients, and

related reading

• The pharma industry from Paul Janssen to today: why drugs got harder to develop and what we can do about it | Alex’s blogatelfo.github.io
• The Degradation Drug - The American Scholartheamericanscholar.org
• The Degradation Drug - The American Scholartheamericanscholar.org
• Anti-psychiatry - Wikipediaen.wikipedia.org
• The evolution of psychiatry - Works in Progress Magazineworksinprogress.co
• The Psychopharmacology Of The FTX Crashastralcodexten.substack.com
• People with psychosis can heal by rebuilding their life storiespsyche.co
• Why Do Mental Illnesses--from Depression to Schizophrenia--Raise the Risk of Dementia? | Scientific Americanscientificamerican.com
• Cardiac Autonomic Dysfunction in Patients with Schizophrenia and Their Healthy Relatives – A Small Reviewpmc.ncbi.nlm.nih.gov
• List of Fictional Drugs Banned By The FDAslatestarcodex.com
• The Right Level of Wrong: Why Psychiatric Conditions Need an Algorithmic Explanationmichaelhalassa.substack.com
• Young men at highest risk of schizophrenia linked with cannabis use disorder | National Institutes of Health (NIH)nih.gov